Radiotherapy for non-melanoma skin cancer in 21st century
Rembielak, Agata
Rembielak, Agata
Citations
Altmetric:
Abstract
Abstract text
The incidence of non-melanoma skin cancer (NMSC) is
rapidly rising worldwide. Although mortality from NMSC is
generally low, the total cost of treatment is becoming a
considerable burden for health care services across the
world due to the number of patients, aging population and
increased complexity of cases which often require a
specialist multidisciplinary approach.
Radiotherapy has been used in NMSC for more than a
century, in radical primary and nodal disease, in
postoperative cases as well as in palliative settings.
Recently there has been an increased interest in the use
of skin radiotherapy in NMSC, not only in view of increased
incidence and aging population but also due to an
advantage that radiotherapy can offer to NMSC patients
for organ and function preservation, particularly in
cosmetically and functionally sensitive areas such as facial
locations.
In her talk Dr Agata Rembielak will discuss the current
status and future perspectives of skin radiotherapy in 21st
century.
Authors
Description
Date
2020
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Rembielak A. SP-0627: Radiotherapy for non-melanoma skin cancer in 21st century. Radiotherapy and Oncology . 2020 Nov;152:S352.